drugset / Trial / NCT07770841

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

NCT07770841 ↗

Phase 3 Recruiting 450 enrolled Novo Nordisk A/S
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to see how oral semaglutide, when taken in lower doses help lowering of body weight in participants with excess body weight when compared to 'dummy' tablets (placebo). Results from this study will help select the most optimal lower dose of oral semaglutide that can be used for treating participants living with overweight or obesity.

Timeline

Start
2026-08-12
Primary completion
2028-02-22
Completion
2028-04-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Semaglutide Peptide — Oral

Indications